Description
ADB-BUTINACA-d9 (Item No. 38341) is intended for use as an internal standard for the quantification of ADB-BUTINACA (Item No. 29350) by GC- or LC-MS. ADB-BUTINACA is categorized as a synthetic cannabinoid.1 ADB-BUTINACA-d9 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
References
[1] SPARKES E, CAIRNS E A, KEVIN R C, et al. Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA†[J]. MedChemComm, 2021, 2: 156-174. DOI:
10.1039/d1md00242b
